About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Prevalence of Thrombosis in COVID-Patients

NCT04615026·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

University Hospital Augsburg

Age

18–any

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

SARS CoV 2 positive swap, at least 4 weeks after infection

You may not be if

under 18 years old no consent anemia

The record

StatusCompleted

PhaseNo phase

Taking part525

StartedNov 2020

UpdatedJun 2, 2022

Conditions

Where1

University Hospital Augsburg
Augsburg, Germany

Clareo Health | Prevalence of Thrombosis in COVID-Patients